TrialAnnals of oncology : official journal of the European Society for Medical Oncology2011

A let-7 microRNA-binding site polymorphism in 3'-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy.

W Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.